Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Canadian Journal of Diabetes|August 12, 2024
Screening and Diagnosis of Chronic Kidney Disease in Adults Living With Diabetes: A Retrospective Cohort Study Using the Canadian Primary Care Sentinel Surveillance NetworkJason E Black, David J T Campbell, Paul E Ronksley, et al.
Canadian Journal of Diabetes|December 28, 2025
Reprint of: Screening and Diagnosis of Chronic Kidney Disease in Adults Living With Diabetes: A Retrospective Cohort Study Using the Canadian Primary Care Sentinel Surveillance NetworkJason E Black, David J T Campbell, Paul E Ronksley, et al.
Diabetes Research and Clinical Practice|May 8, 2025
Young adults with type 2 diabetes experience high rates of Level 3 Hypoglycemia: A subgroup analysis of the Real-World iNPHORM cohortYu Kuei Lin, Jason E Black, Stewart B Harris, et al.
Jac-Antimicrobial Resistance|October 31, 2024
Evaluating the costs of Escherichia coli bloodstream infections: a population-based cohort study in a large metropolitan Canadian regionTeagan L King, Elissa Rennert-May, Ranjani Somayaji, et al.
BMJ Open|September 3, 2021
COVID-19 hinterland: surveilling the self-reported impacts of the pandemic on diabetes management in the USA (cross-sectional results of the iNPHORM study)Alexandria A Ratzki-Leewing, Bridget L Ryan, John D Buchenberger, et al.
Family Practice|September 23, 2025
An overview of developing clinical prediction models in family practiceSharmala Thuraisingam, Jason E Black, Michelle M Dowsey, et al.
Diabetes, Obesity & Metabolism|September 13, 2023
Severe (level 3) hypoglycaemia occurrence in a real-world cohort of adults with type 1 or 2 diabetes mellitus (iNPHORM, United States)Alexandria Ratzki-Leewing, Jason E Black, Anna R Kahkoska, et al.
Diabetes, Obesity & Metabolism|July 6, 2023
Development and validation of a real-world model to predict 1-year Level 3 (severe) hypoglycaemia risk in adults with diabetes (the iNPHORM study, United States)Alexandria A Ratzki-Leewing, Jason E Black, Bridget L Ryan, et al.
Diabetes, Obesity & Metabolism|November 3, 2025
Real-world incidence and risk factors of level 3 (severe) hypoglycaemia in adults with type 1 or 2 diabetes (iNPHORM, United States)Alexandria Ratzki-Leewing, Jason E Black, Jasminder Bhatti, et al.
JMIR Research Protocols|January 13, 2022
Predicting Real-world Hypoglycemia Risk in American Adults With Type 1 or 2 Diabetes Mellitus Prescribed Insulin and/or Secretagogues: Protocol for a Prospective, 12-Wave Internet-Based Panel Survey With Email Support (the iNPHORM [Investigating Novel Predictions of Hypoglycemia Occurrence Using Real-world Models] Study)Alexandria Ratzki-Leewing, Bridget L Ryan, Guangyong Zou, et al.
Pageof 3